Na Guo Selected Research

Atrial Natriuretic Factor (ANF)

11/2020	HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
1/2020	Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Na Guo Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 01/2011
15	Inflammation (Inflammations) 11/2023 - 06/2013
15	Infections 06/2023 - 11/2011
11	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2013
7	Hypoxia (Hypoxemia) 09/2023 - 02/2013
7	Pain (Aches) 01/2022 - 01/2021
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2019
6	Glioma (Gliomas) 01/2020 - 12/2016
5	Carcinogenesis 04/2024 - 08/2011
5	Tuberculosis (Tuberculoses) 01/2014 - 04/2011
4	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2016
4	Heart Failure 01/2024 - 10/2014
4	Body Weight (Weight, Body) 01/2024 - 01/2016
4	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 01/2016
4	Vomiting 08/2022 - 01/2021
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2018
4	Hypertrophy 01/2021 - 01/2020
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 04/2013
3	Myocardial Infarction 02/2024 - 01/2020
3	Insulin Resistance 01/2024 - 12/2018
3	Brain Ischemia (Cerebral Ischemia) 01/2024 - 11/2012
3	Constipation 11/2023 - 01/2021
3	Colonic Neoplasms (Colon Cancer) 08/2023 - 04/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 10/2010
3	Hyperthermia 09/2022 - 06/2014
3	Hypertension (High Blood Pressure) 01/2022 - 02/2012
3	Nausea 01/2022 - 01/2021
3	Obesity 01/2022 - 12/2018
3	Frailty 09/2021 - 01/2021
3	Coronary Disease (Coronary Heart Disease) 08/2021 - 10/2010
3	Autolysis 01/2015 - 01/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2024 - 04/2024
2	Osteoporosis 05/2024 - 08/2012
2	Stomach Neoplasms (Stomach Cancer) 04/2024 - 09/2020
2	Lymphoma (Lymphomas) 03/2024 - 07/2012
2	Hearing Loss (Hearing Impairment) 02/2024 - 01/2022
2	Cardiomegaly (Heart Hypertrophy) 01/2024 - 11/2020
2	Ischemic Stroke 01/2024 - 01/2022
2	Reperfusion Injury 01/2024 - 01/2023
2	Dysbiosis 12/2023 - 11/2023
2	Hemorrhage 11/2023 - 01/2023
2	HIV Infections (HIV Infection) 11/2023 - 05/2020
2	Pathologic Processes 10/2023 - 01/2014
2	Acute Kidney Injury (Acute Renal Failure) 10/2023 - 08/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2023 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 01/2020
2	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2022
2	Foodborne Diseases 01/2023 - 03/2022

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2011
9	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2014
8	Small Interfering RNA (siRNA)IBA 04/2023 - 01/2016
6	CytokinesIBA 01/2022 - 02/2009
5	phthalic acid (phthalate)IBA 11/2023 - 02/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 03/2013
4	Peptides (Polypeptides)IBA 11/2023 - 01/2014
4	Interleukin-17 (Interleukin 17)IBA 11/2023 - 01/2019
4	Sirolimus (Rapamycin)FDA Link 11/2022 - 11/2011
4	Messenger RNA (mRNA)IBA 08/2022 - 08/2014
4	MicroRNAs (MicroRNA)IBA 04/2022 - 11/2011
3	LipidsIBA 01/2024 - 10/2019
3	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2021
3	Capsules (Microcapsules)IBA 11/2023 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 03/2013
3	Enterotoxins (Enterotoxin)IBA 01/2023 - 10/2015
3	Liposomes (Liposome)IBA 09/2022 - 12/2020
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2021
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 01/2015
3	TOR Serine-Threonine KinasesIBA 11/2020 - 08/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020 - 01/2020
3	Myosin Heavy Chains (Myosin Heavy Chain)IBA 11/2020 - 01/2020
3	Dexmedetomidine FDA Link 01/2020 - 08/2017
3	Amino Acids FDA Link 01/2019 - 10/2014
2	EsketamineIBA 04/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 01/2016
2	Arginine (L-Arginine)FDA Link 02/2024 - 01/2022
2	CateninsIBA 01/2024 - 01/2022
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2024 - 11/2020
2	Bile Acids and Salts (Bile Acids)IBA 12/2023 - 01/2023
2	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 01/2016
2	E-SelectinIBA 11/2023 - 07/2021
2	SolutionsIBA 11/2023 - 01/2016
2	urinastatin (MR 20)IBA 10/2023 - 06/2014
2	IronIBA 10/2023 - 01/2020
2	puerarinIBA 09/2023 - 04/2022
2	daidzeinIBA 09/2023 - 01/2018
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 10/2022
2	Staphylococcal enterotoxin AIBA 01/2023 - 01/2022
2	Bacterial ToxinsIBA 01/2023 - 03/2022

Therapy/Procedure

21	Therapeutics 01/2024 - 01/2011
13	Drug Therapy (Chemotherapy) 02/2024 - 07/2012
6	Immunotherapy 11/2023 - 01/2017
6	Radiotherapy 01/2022 - 04/2017
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 10/2014
5	Analgesia 01/2022 - 01/2018
3	Hysterectomy 01/2023 - 08/2010
3	Intravenous Injections 01/2019 - 07/2016
2	Percutaneous Coronary Intervention 10/2022 - 10/2010